November 2025 didn't standardize state hemp law — it accelerated the divergence. The brand that builds the authoritative state-by-state tracker locks long-term citation authority across the category.
SAFE Banking has been "almost passing" for seven years. The communications stakes just got higher. Schedule III rescheduling raised institutional investor interest. The operators that build the right banking narrative now win citation share — whether SAFER passes or doesn't.
280E has crushed cannabis P&Ls for fifteen years. The April 23 Schedule III order ended it — for some operators. The MSOs that communicate the partial repeal with discipline win the post-rescheduling citation graph. The rest don't.
The April 23 Schedule III order didn't unlock NYSE and NASDAQ for cannabis. It cracked the door for one category. The operators that move first will reset the public-market narrative — if their communications is ready.
Multi-state operators chase national citation share. Single-state operators don't need it. They need total dominance of the AI answer for one state. Inside the playbook.
Verano, Cresco, and Cannabist sit in the tier below the top three MSOs. Three operators. Three strategies. Three citation profiles. Inside the comparative AI citation share audit.
GTI isn't the largest U.S. cannabis operator. It isn't the most profitable in absolute terms. But it holds the highest citation share inside AI engines among major MSOs. Here's why — and what competitors should learn.
Curaleaf is the largest publicly traded U.S. MSO by revenue. Ask the AI engines and you'll get a different answer. Inside the citation gap — and the six plays that close it.
Schedule III hit April 28, 2026. DEA June 29 hearing on adult-use. State-by-state. NCIA, USCC, MPP. The 2026 cannabis public affairs landscape.
How cannabis brands build visibility across AI search systems — why the category is uniquely challenging for AI retrieval, the role of Reddit and trade press, compliance considerations, and the disciplines that work.
